J. Goldman & CO LP Amarin Corp Plcuk Transaction History

J. Goldman & CO LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $774,027 - $1.65 Million	-212,645 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $1.02 Million - $1.76 Million	212,645 New	212,645 $1.47 Million
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $3.57 Million - $5.95 Million	-256,915 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $3.91 Million - $4.93 Million	240,224 Added 1439.24%	256,915 $4.98 Million
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $1.69 Million - $3 Million	-134,392 Reduced 88.95%	16,691 $347,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $1.87 Million - $3.47 Million	151,083 New	151,083 $2.06 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $194M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.